Some cardiovascular effects of a series of aryloxyalkylamines. II.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D002490:Central Nervous System / Q000187:drug effects*; D002625:Chemistry, Organic; D003863:Depression / Q000139:chemically induced; D004285:Dogs; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005021:Ethylamines / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007022:Hypotension / Q000139:chemically induced*; D009638:Norepinephrine / Q000494:pharmacology; D055601:Organic Chemistry Phenomena; D051381:Rats; D013610:Tachycardia / Q000139:chemically induced
D000959:Antihypertensive Agents; D005021:Ethylamines; D009638:Norepinephrine; D004837:Epinephrine